Novo Nordisk A/S (NVO) News Today $55.27 -0.23 (-0.42%) As of 03:09 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Why Is Novo Nordisk A/S Down Today?Toggle Visibility of Why Is Novo Nordisk A/S Down Today?Novo Nordisk A/S (NVO) shares are trading lower after a flurry of mixed news—positive pipeline and partnership developments countered by multiple class‐action filings and a major analyst downgrade. Positive Sentiment: Expanding obesity pipeline with next‐generation candidates beyond Wegovy and Ozempic to defend its market lead. Can NVO Maintain Obesity Leadership With Next-Generation Candidates? Positive Sentiment: Telehealth partner LifeMD will offer Ozempic at $499/month for eligible cash-paying U.S. patients, potentially boosting volume in under-insured segments. LifeMD to offer Novo's Ozempic at $499 per month to eligible US cash-paying customers Positive Sentiment: Zacks highlights NVO as a top long-term growth stock based on strong earnings trends and robust GLP-1 franchise. Why Novo Nordisk (NVO) is a Top Growth Stock for the Long-Term Positive Sentiment: Seeking Alpha argues that key growth myths don’t hold up and that Wegovy’s higher doses and cardiovascular benefits sustain NVO’s competitive edge. The Truth About Novo Nordisk: 4 Myths That Don't Hold Up Neutral Sentiment: The Motley Fool sees NVO’s 2025 stock pullback as a potential buying opportunity ahead of an expected oral weight-loss launch. Why Is Novo Nordisk Stock Down in 2025, and Is It a Buying Opportunity? Neutral Sentiment: Heartseed regains global rights after ending its regenerative medicine partnership with Novo Nordisk, trimming NVO’s pipeline collaborations. Heartseed Regains Rights After Novo Nordisk Partnership Ends Negative Sentiment: Multiple law firms have filed or reminded investors of securities class actions against Novo Nordisk alleging misstated growth and disclosures, with lead-plaintiff deadlines looming. NVO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Negative Sentiment: Morgan Stanley downgraded NVO to underweight, citing stagnating demand for its weight-loss drugs and potential late-stage pipeline failures. Here's Why Morgan Stanley Analysts Downgraded Novo Nordisk's Stock Posted 1h agoAI Generated. May Contain Errors. NVO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period LifeMD Offers Novo Nordisk’s Ozempic For $499 A Month To Eligible Patients2 hours ago | msn.comDenmark's Economy Wobbles as Novo Nordisk Loses Steam2 hours ago | finance.yahoo.comNVO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit4 hours ago | globenewswire.comDEADLINE ALERT for NVO and LINE: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders4 hours ago | globenewswire.comFINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk5 hours ago | businesswire.comThe Truth About Novo Nordisk: 4 Myths That Don't Hold UpSeptember 30 at 10:00 AM | seekingalpha.comLifeMD to offer Novo's Ozempic at $499 per month to eligible US cash-paying customersSeptember 30 at 8:14 AM | reuters.comLockerman Financial Group Inc. Takes Position in Novo Nordisk A/S $NVOSeptember 30 at 7:35 AM | marketbeat.comWhy Is Novo Nordisk Stock Down in 2025, and Is It a Buying Opportunity?September 30 at 7:01 AM | fool.comNovo Nordisk A/S $NVO is Oak Family Advisors LLC's 5th Largest PositionSeptember 30 at 5:52 AM | marketbeat.comNovo Nordisk A/S $NVO Holdings Boosted by Bennett Selby Investments LPSeptember 30 at 5:44 AM | marketbeat.comJanney Capital Management LLC Purchases New Shares in Novo Nordisk A/S $NVOSeptember 30 at 5:13 AM | marketbeat.comVenture Visionary Partners LLC Increases Holdings in Novo Nordisk A/S $NVOSeptember 30 at 4:55 AM | marketbeat.comIndependence Bank of Kentucky Sells 8,965 Shares of Novo Nordisk A/S $NVOSeptember 30 at 4:21 AM | marketbeat.comHeartseed Regains Rights After Novo Nordisk Partnership EndsSeptember 29 at 9:11 PM | tipranks.comNVO Deadline: NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud LawsuitSeptember 29 at 4:28 PM | prnewswire.comClass Action Filed Against Novo Nordisk A/S (NVO) - September 30, 2025 Deadline to Join – Contact The Gross Law FirmSeptember 29 at 4:15 PM | globenewswire.comNVO DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors With Losses in Excess of $100k to Secure Counsel Before Important September 30 Deadline in Securities Class Action - NVOSeptember 29 at 4:03 PM | globenewswire.comNovo Nordisk Stock Is Downgraded. There’s a ‘Tough Path Ahead.’September 29 at 3:52 PM | msn.comMorgan Stanley Downgrades Novo Nordisk A (NVO)September 29 at 3:52 PM | msn.comDeadline Soon: Novo Nordisk A/S (NVO) Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud LawsuitSeptember 29 at 3:52 PM | tmcnet.comNovo Nordisk A/S (NYSE:NVO) Shares Gap Down - Time to Sell?September 29 at 2:48 PM | marketbeat.comHere's Why Morgan Stanley Analysts Downgraded Novo Nordisk's StockSeptember 29 at 2:35 PM | investopedia.comPortnoy Law Firm Announces Class Action on Behalf of Novo Nordisk A/S InvestorsSeptember 29 at 1:39 PM | globenewswire.comNOVO URGENT DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urges Novo Nordisk Investors to Contact the Firm Before September 30thSeptember 29 at 10:14 AM | globenewswire.comNovo Nordisk Stock Is Downgraded. There's a ‘Tough Path Ahead.September 29 at 10:13 AM | barrons.comNovo Nordisk A/S Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - NVOSeptember 29 at 8:45 AM | prnewswire.comPremarket movers: Merus, GSK, Novo NordiskSeptember 29 at 7:38 AM | marketwatch.comWhy Wegovy Maker Novo Nordisk’s Stock Is Sliding 3% Premarket TodaySeptember 29 at 7:38 AM | msn.comSmith Chas P & Associates PA Cpas Has $13.63 Million Stock Holdings in Novo Nordisk A/S $NVOSeptember 29 at 7:12 AM | marketbeat.comElser Financial Planning Inc Has $876,000 Stock Holdings in Novo Nordisk A/S $NVOSeptember 29 at 7:12 AM | marketbeat.comNovo Nordisk A/S $NVO Shares Purchased by Generate Investment Management LtdSeptember 29 at 6:01 AM | marketbeat.comCapital Insight Partners LLC Sells 4,702 Shares of Novo Nordisk A/S $NVOSeptember 29 at 5:34 AM | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming Deadlines - NVOSeptember 28 at 10:00 AM | prnewswire.comAssessing Novo Nordisk’s Value After Major Stock Slide and Latest FDA Approval in 2025September 28 at 8:12 AM | finance.yahoo.comDoes Novo Nordisk’s Sharp 10% Drop Signal a New Opportunity for Investors in 2025?September 28 at 8:12 AM | finance.yahoo.comFinancial Partners Group LLC Increases Stock Position in Novo Nordisk A/S $NVOSeptember 28 at 7:52 AM | marketbeat.comKathmere Capital Management LLC Has $621,000 Stock Holdings in Novo Nordisk A/S $NVOSeptember 28 at 6:02 AM | marketbeat.com3 Magnificent Stocks Under $100 to Buy Right NowSeptember 27 at 6:45 AM | fool.comSignaturefd LLC Raises Stake in Novo Nordisk A/S $NVOSeptember 27 at 5:43 AM | marketbeat.comNovo Nordisk A/S $NVO Shares Acquired by Meridian Investment Counsel Inc.September 27 at 5:43 AM | marketbeat.comBanque Pictet & Cie SA Has $3.58 Million Stake in Novo Nordisk A/S $NVOSeptember 27 at 5:43 AM | marketbeat.comNovo Nordisk CEO raises doubts over Trump’s drug tariffs and EU-US trade pactSeptember 26, 2025 | msn.comNovo Nordisk A/S (NVO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitSeptember 26, 2025 | prnewswire.comNovo Nordisk A/S Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – NVOSeptember 26, 2025 | businesswire.comA New Prescription For Pain: Understanding Trump's 100% Pharma TariffSeptember 26, 2025 | seekingalpha.comBig Pharma braces for the next price cutSeptember 26, 2025 | proactiveinvestors.comNVO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitSeptember 26, 2025 | globenewswire.comNOVO DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urges Novo Nordisk Investors to Contact the Firm Before September 30thSeptember 26, 2025 | globenewswire.comNovo Nordisk: Wegovy Sales Soar, Trump Tariffs No ThreatSeptember 26, 2025 | seekingalpha.com Get Novo Nordisk A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for NVO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Videos NVO Media Mentions By Week NVO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVO News Sentiment▼0.550.90▲Average Medical News Sentiment NVO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVO Articles This Week▼8066▲NVO Articles Average Week Get the Latest News and Ratings for NVO and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Novo Nordisk A/S and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Novartis News Today AstraZeneca News Today Sanofi News Today GSK News Today Takeda Pharmaceutical News Today argenex News Today BeOne Medicines News Today Insmed News Today BioNTech News Today Teva Pharmaceutical Industries News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NVO) was last updated on 9/30/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novo Nordisk A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Novo Nordisk A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
